Tag: China oncology,NSCLC,Press Releases,Veristrat,cancer diagnostics,liquid biopsy,personalized medicine,proteomic biomarkers,serum protein test
-
Biodesix® and Bioyong Announce Agreement for Joint Development and Commercialization of VeriStrat® Test in Greater China
US $38M; Potential Expansion into Other Asia/Pacific Countries, Additional Liquid Biopsy Products